Compare STRO & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRO | SY |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | China |
| Employees | 131 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 272.8M |
| IPO Year | N/A | 2018 |
| Metric | STRO | SY |
|---|---|---|
| Price | $34.99 | $2.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $28.00 | $5.50 |
| AVG Volume (30 Days) | 223.8K | ★ 415.0K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $38.64 |
| Revenue Next Year | N/A | $30.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $0.75 |
| 52 Week High | $36.00 | $6.28 |
| Indicator | STRO | SY |
|---|---|---|
| Relative Strength Index (RSI) | 72.00 | 52.20 |
| Support Level | $0.78 | $2.80 |
| Resistance Level | N/A | $2.93 |
| Average True Range (ATR) | 2.61 | 0.12 |
| MACD | 0.25 | 0.02 |
| Stochastic Oscillator | 87.24 | 85.37 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.